$8.43
-0.16-1.86%
At close: -
$8.43
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Amicus Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:FOLD | Benzinga
Amicus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$0.050
Quarterly Revenue Estimate
$142.00M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$528.29M
Analyze the earnings history of Amicus Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FOLD | Amicus Therapeutics | -$0.02 | $0.05 | — | — | $110.40M | $142.00M | — | — | 05/08/2025 | Get Alert |
| FOLD | Amicus Therapeutics | $0.01 | $0.09 | $0.09 | 0.00% | $115.08M | $147.87M | $149.71M | 1.24% | 02/19/2025 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.01 | $0.00 | $0.10 | 100.00% | $103.50M | $135.33M | $141.52M | 4.57% | 11/06/2024 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.07 | -$0.05 | $0.06 | 220.00% | $94.50M | $121.43M | $126.67M | 4.31% | 08/08/2024 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.06 | -$0.07 | -$0.02 | 71.43% | $86.27M | $111.19M | $110.40M | -0.71% | 05/09/2024 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.19 | -$0.06 | $0.01 | 116.67% | $88.10M | $114.33M | $115.08M | 0.65% | 02/28/2024 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.12 | -$0.08 | -$0.07 | 12.50% | $81.69M | $101.36M | $103.50M | 2.11% | 11/08/2023 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.21 | -$0.12 | -$0.15 | -25.00% | $80.73M | $89.87M | $94.50M | 5.16% | 08/08/2023 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.30 | -$0.15 | -$0.18 | -20.00% | $78.72M | $83.08M | $86.27M | 3.84% | 05/10/2023 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.29 | -$0.13 | -$0.19 | -46.15% | $82.15M | $86.29M | $88.10M | 2.09% | 03/01/2023 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.19 | -$0.19 | -$0.12 | 36.84% | $79.55M | $84.22M | $81.69M | -3.00% | 11/07/2022 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.19 | -$0.22 | -$0.21 | 4.55% | $77.41M | $85.89M | $80.73M | -6.01% | 08/04/2022 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.25 | -$0.25 | -$0.30 | -20.00% | $66.40M | $77.13M | $78.72M | 2.05% | 05/09/2022 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.27 | -$0.16 | -$0.29 | -81.25% | $70.57M | $83.28M | $82.15M | -1.35% | 02/24/2022 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.22 | -$0.18 | -$0.19 | -5.56% | $67.44M | $80.11M | $79.55M | -0.71% | 11/09/2021 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.20 | -$0.22 | -$0.19 | 13.64% | $62.35M | $73.36M | $77.41M | 5.52% | 08/05/2021 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.35 | -$0.24 | -$0.25 | -4.17% | $60.52M | $71.65M | $66.40M | -7.32% | 05/10/2021 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.35 | -$0.23 | -$0.27 | -17.39% | $55.29M | $70.06M | $70.57M | 0.73% | 03/01/2021 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.24 | -$0.22 | -$0.22 | 0.00% | $48.77M | $65.10M | $67.44M | 3.59% | 11/05/2020 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.36 | -$0.26 | -$0.20 | 23.08% | $44.13M | $62.38M | $62.35M | -0.04% | 08/10/2020 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.39 | -$0.28 | -$0.35 | -25.00% | $34.05M | $57.49M | $60.52M | 5.28% | 05/07/2020 | Get Alert |
Amicus Therapeutics (FOLD) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-19 | $0.09 | $0.09 | 0.00 % |
| Q3 | 2024-11-06 | $0.10 | $0 | 100.0 % |
| Q2 | 2024-08-08 | $0.06 | $-0.05 | 220.0 % |
| Q1 | 2024-05-09 | $-0.02 | $-0.07 | 71.4 % |
Amicus Therapeutics (FOLD) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-19 | $149.71M | $147.87M | 1.24 % |
| Q3 | 2024-11-06 | $141.52M | $135.33M | 4.57 % |
| Q2 | 2024-08-08 | $126.67M | $121.43M | 4.31 % |
| Q1 | 2024-05-09 | $110.40M | $111.19M | -0.71 % |
FAQ
When is Amicus Therapeutics (NASDAQ:FOLD) reporting earnings?
Amicus Therapeutics (FOLD) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 19, 2025 for Q4.
What were the latest earnings per share (EPS) for Amicus Therapeutics (NASDAQ:FOLD)?
The Actual EPS was $0.09, which hit the estimate of $0.09.
What were Amicus Therapeutics’s (NASDAQ:FOLD) revenues?
The Actual Revenue was $149.7M, which beat the estimate of $147.9M.
Browse earnings estimates, EPS, and revenue on all stocks.